$KRO
KRONOS WORLDWIDE INC

2023 Q2 Form 10-Q Financial Statement

#000155837023007841 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $443.2M $426.3M
YoY Change -21.6% -24.27%
Cost Of Revenue $399.1M $395.5M
YoY Change -10.27% -4.38%
Gross Profit $44.10M $30.80M
YoY Change -63.4% -79.37%
Gross Profit Margin 9.95% 7.22%
Selling, General & Admin $50.10M $53.20M
YoY Change -20.73% -13.36%
% of Gross Profit 113.61% 172.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.60M $12.90M
YoY Change -11.45% 0.0%
% of Gross Profit 26.3% 41.88%
Operating Expenses $54.40M $53.20M
YoY Change -13.92% -13.36%
Operating Profit -$10.30M -$18.30M
YoY Change -115.8% -121.97%
Interest Expense -$300.0K $4.200M
YoY Change -106.98% -6.67%
% of Operating Profit
Other Income/Expense, Net -$2.200M -$900.0K
YoY Change -29.03% -71.88%
Pretax Income -$12.30M -$22.10M
YoY Change -120.26% -129.16%
Income Tax -$4.100M -$6.900M
% Of Pretax Income
Net Earnings -$8.200M -$15.20M
YoY Change -117.86% -126.43%
Net Earnings / Revenue -1.85% -3.57%
Basic Earnings Per Share -$0.07 -$0.13
Diluted Earnings Per Share -$0.07 -$0.13
COMMON SHARES
Basic Shares Outstanding 115.1M 115.3M
Diluted Shares Outstanding 115.1M 115.3M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $169.4M $177.8M
YoY Change -54.36% -49.2%
Cash & Equivalents $169.4M $177.8M
Short-Term Investments
Other Short-Term Assets $37.60M $42.60M
YoY Change 0.53% -12.88%
Inventory $540.7M $612.7M
Prepaid Expenses
Receivables $282.3M $268.1M
Other Receivables $25.70M $33.90M
Total Short-Term Assets $1.056B $1.135B
YoY Change -15.4% -11.29%
LONG-TERM ASSETS
Property, Plant & Equipment $510.9M $489.9M
YoY Change 8.24% -2.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $123.1M $116.1M
YoY Change 9.42% 5.55%
Other Assets $89.10M $13.40M
YoY Change 575.0% -8.84%
Total Long-Term Assets $723.1M $696.4M
YoY Change 1.05% -7.86%
TOTAL ASSETS
Total Short-Term Assets $1.056B $1.135B
Total Long-Term Assets $723.1M $696.4M
Total Assets $1.779B $1.832B
YoY Change -9.41% -10.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $153.7M $144.6M
YoY Change 11.46% 9.13%
Accrued Expenses $40.70M $34.80M
YoY Change -1.93% -24.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $700.0K $900.0K
YoY Change -50.0% -35.71%
Total Short-Term Liabilities $260.6M $259.7M
YoY Change -7.42% -7.61%
LONG-TERM LIABILITIES
Long-Term Debt $432.4M $433.5M
YoY Change 3.99% -2.32%
Other Long-Term Liabilities $183.4M $20.80M
YoY Change 645.53% -20.91%
Total Long-Term Liabilities $615.8M $659.7M
YoY Change -20.89% -21.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $260.6M $259.7M
Total Long-Term Liabilities $615.8M $659.7M
Total Liabilities $902.3M $919.4M
YoY Change -14.87% -18.04%
SHAREHOLDERS EQUITY
Retained Earnings -$172.6M -$142.5M
YoY Change 175.72% 64.74%
Common Stock $1.391B $1.394B
YoY Change -0.29% -0.16%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.500M
YoY Change 36.36%
Treasury Stock Shares
Shareholders Equity $876.5M $912.1M
YoY Change
Total Liabilities & Shareholders Equity $1.779B $1.832B
YoY Change -9.41% -10.01%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$8.200M -$15.20M
YoY Change -117.86% -126.43%
Depreciation, Depletion And Amortization $11.60M $12.90M
YoY Change -11.45% 0.0%
Cash From Operating Activities $33.20M -$109.8M
YoY Change -51.1% 490.32%
INVESTING ACTIVITIES
Capital Expenditures $17.50M $16.40M
YoY Change -207.36% 15.49%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$17.50M -$16.40M
YoY Change 8.02% 15.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $200.0K
YoY Change 0.0%
Cash From Financing Activities -23.60M -23.50M
YoY Change 6.79% 1.29%
NET CHANGE
Cash From Operating Activities 33.20M -109.8M
Cash From Investing Activities -17.50M -16.40M
Cash From Financing Activities -23.60M -23.50M
Net Change In Cash -7.900M -133.3M
YoY Change -126.69% 218.9%
FREE CASH FLOW
Cash From Operating Activities $33.20M -$109.8M
Capital Expenditures $17.50M $16.40M
Free Cash Flow $15.70M -$126.2M
YoY Change -81.35% 284.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1400000
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-31763
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1100000
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
81300000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
81300000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
124400000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
124400000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115500000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115300000
CY2023Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001257640
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
KRONOS WORLDWIDE, INC.
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0294959
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
5430 LBJ Freeway
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1700
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75240-2620
CY2023Q1 dei City Area Code
CityAreaCode
972
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
233-1700
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock
CY2023Q1 dei Trading Symbol
TradingSymbol
KRO
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
115057816
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
327800000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177800000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2000000.0
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1600000
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
255100000
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
302000000.0
CY2022Q4 us-gaap Inventory Net
InventoryNet
608700000
CY2023Q1 us-gaap Inventory Net
InventoryNet
612700000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
48600000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
41000000.0
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1242200000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1135100000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
112900000
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
113600000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4800000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4800000
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3200000
CY2023Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
2500000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21500000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21300000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
52000000.0
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
50900000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13300000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13400000
CY2022Q4 kro Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
207700000
CY2023Q1 kro Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
206500000
CY2022Q4 us-gaap Land
Land
41900000
CY2023Q1 us-gaap Land
Land
42200000
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
214700000
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
220200000
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1093200000
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1109200000
CY2022Q4 kro Mining Properties
MiningProperties
119600000
CY2023Q1 kro Mining Properties
MiningProperties
113200000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
76500000
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
83900000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1545900000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1568700000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1061400000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1078800000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
484500000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
489900000
CY2022Q4 us-gaap Assets
Assets
1934400000
CY2023Q1 us-gaap Assets
Assets
1831500000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1100000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
900000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
312300000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
251800000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
13300000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
7000000.0
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
326700000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
259700000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
424100000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
433500000
CY2022Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
128600000
CY2023Q1 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
129300000
CY2022Q4 us-gaap Due To Affiliate Noncurrent
DueToAffiliateNoncurrent
33500000
CY2023Q1 us-gaap Due To Affiliate Noncurrent
DueToAffiliateNoncurrent
33500000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17400000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17200000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26400000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
25400000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20500000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20800000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
650500000
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
659700000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1200000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1200000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1394300000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1393000000.0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105400000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-142500000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-331500000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-338100000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1400000
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1500000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
957200000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
912100000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1934400000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1831500000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
562900000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
426300000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
413600000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
395500000
CY2022Q1 us-gaap Gross Profit
GrossProfit
149300000
CY2023Q1 us-gaap Gross Profit
GrossProfit
30800000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61400000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53200000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1500000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5400000
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-3100000
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1300000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
83300000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-18300000
CY2022Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
100000
CY2023Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
2000000.0
CY2022Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
100000
CY2023Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-700000
CY2022Q1 us-gaap Defined Benefit Plan Other Costs
DefinedBenefitPlanOtherCosts
3200000
CY2023Q1 us-gaap Defined Benefit Plan Other Costs
DefinedBenefitPlanOtherCosts
900000
CY2022Q1 us-gaap Interest Expense
InterestExpense
4500000
CY2023Q1 us-gaap Interest Expense
InterestExpense
4200000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
75800000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22100000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18300000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6900000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
57500000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-15200000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115500000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115300000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
57500000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-15200000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
6600000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-7000000.0
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8900000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6600000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
66400000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21800000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
870200000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
57500000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8900000
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.19
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
21900000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1100000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
913600000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
957200000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-15200000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6600000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.19
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
21900000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1400000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
912100000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
57500000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-15200000
CY2022Q1 us-gaap Depreciation
Depreciation
12900000
CY2023Q1 us-gaap Depreciation
Depreciation
12900000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1400000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1100000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1700000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1100000
CY2022Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
1600000
CY2023Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
-2200000
CY2022Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
100000
CY2023Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-700000
CY2022Q1 kro Equity Method Investment Distributions From Contributions To Net
EquityMethodInvestmentDistributionsFromContributionsToNet
-3800000
CY2023Q1 kro Equity Method Investment Distributions From Contributions To Net
EquityMethodInvestmentDistributionsFromContributionsToNet
-700000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1600000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-400000
CY2022Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
41200000
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
39000000.0
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32800000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-500000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8900000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8100000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-25200000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-60000000.0
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
6400000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2600000
CY2022Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-9800000
CY2023Q1 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
15100000
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-500000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-200000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18600000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-109800000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14200000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16400000
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
200000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
200000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
21900000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
21900000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23200000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23500000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-56000000.0
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-149700000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-400000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-700000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
412600000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
334600000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
356200000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
184200000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
8300000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
7900000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5500000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2600000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3800000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6400000
CY2023Q1 kro Organization
Organization
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Organization</i> - At March 31, 2023, Valhi, Inc. (NYSE: VHI) held approximately 50% of our outstanding common stock and a wholly-owned subsidiary of NL Industries, Inc. (NYSE: NL) held approximately 31% of our common stock. Valhi owned approximately 83% of NL’s outstanding common stock and a wholly-owned subsidiary of Contran Corporation held approximately 92% of Valhi’s outstanding common stock. A majority of Contran’s outstanding voting stock is held directly by Lisa K. Simmons and various family trusts established for the benefit of Ms. Simmons, Thomas C. Connelly (the husband of Ms. Simmons’ late sister) and their children and for which Ms. Simmons or Mr. Connelly, as applicable, serve as trustee (collectively, the “Other Trusts”). With respect to the Other Trusts for which Mr. Connelly serves as trustee, he is required to vote the shares of Contran voting stock held in such trusts in the same manner as Ms. Simmons. Such voting rights of Ms. Simmons last through April 22, 2030 and are personal to Ms. Simmons. The remainder of Contran’s outstanding voting stock is held by another trust (the “Family Trust”), which was established for the benefit of Ms. Simmons and her late sister and their children and for which a third-party financial institution serves as trustee. Consequently, at March 31, 2023, Ms. Simmons and the Family Trust may be deemed to control Contran, and therefore may be deemed to indirectly control the wholly-owned subsidiary of Contran, Valhi, NL and us.</p>
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3500000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3500000
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
255100000
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
302000000.0
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
145300000
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
158900000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
32000000.0
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
36700000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
349900000
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
333700000
CY2022Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
81500000
CY2023Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
83400000
CY2022Q4 us-gaap Inventory Net
InventoryNet
608700000
CY2023Q1 us-gaap Inventory Net
InventoryNet
612700000
CY2023Q1 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-200000
CY2022Q1 kro Incremental Tax Expense Benefit On Equity In Earnings
IncrementalTaxExpenseBenefitOnEquityInEarnings
-400000
CY2022Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-100000
CY2023Q1 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
200000
CY2022Q1 kro Income Tax Reconciliation Global Intangible Low Tax Income Net
IncomeTaxReconciliationGlobalIntangibleLowTaxIncomeNet
900000
CY2023Q1 kro Income Tax Reconciliation Global Intangible Low Tax Income Net
IncomeTaxReconciliationGlobalIntangibleLowTaxIncomeNet
-500000
CY2022Q1 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-800000
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
1100000
CY2023Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
900000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
425200000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
434400000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1100000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
900000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
424100000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
433500000
CY2022Q4 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
5900000
CY2023Q1 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
5900000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
177200000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
144600000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25600000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8300000
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
22900000
CY2023Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
22800000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3800000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3700000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
59900000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
50400000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
312300000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
251800000
CY2022Q4 kro Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
4800000
CY2023Q1 kro Employee Related Liabilities Noncurrent
EmployeeRelatedLiabilitiesNoncurrent
4900000
CY2022Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
9800000
CY2023Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
10000000.0
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20500000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20800000
CY2022Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
3000000.0
CY2023Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1600000
CY2022Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2900000
CY2023Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
5100000
CY2022Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3100000
CY2023Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
4800000
CY2022Q1 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-3400000
CY2023Q1 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-600000
CY2022Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
6200000
CY2023Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
2500000
CY2023Q1 us-gaap Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear
17000000
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
15900000
CY2023Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4600000
CY2022Q1 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
2000000.0
CY2023Q1 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-1200000
CY2023Q1 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-400000
CY2022Q1 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
800000
CY2023Q1 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-200000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18300000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6900000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18300000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6900000
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-1100000
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-100000
CY2022Q1 kro Comprehensive Income Loss Tax
ComprehensiveIncomeLossTax
19400000
CY2023Q1 kro Comprehensive Income Loss Tax
ComprehensiveIncomeLossTax
-6800000
CY2023Q1 kro Deferred Income Tax Expense Benefit Non Cash
DeferredIncomeTaxExpenseBenefitNonCash
-1000000.0
CY2022Q1 kro Deferred Income Tax Expense Benefit Non Cash
DeferredIncomeTaxExpenseBenefitNonCash
1100000
CY2023Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
2000000.0
CY2023Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
1171536
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
334600000
CY2022Q4 kro Cash Cash Equivalents And Restricted Cash Fair Value Disclosure
CashCashEquivalentsAndRestrictedCashFairValueDisclosure
334600000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
184200000
CY2023Q1 kro Cash Cash Equivalents And Restricted Cash Fair Value Disclosure
CashCashEquivalentsAndRestrictedCashFairValueDisclosure
184200000
CY2022Q4 us-gaap Senior Notes
SeniorNotes
424100000
CY2022Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
374200000
CY2023Q1 us-gaap Senior Notes
SeniorNotes
433500000
CY2023Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
389400000
CY2023Q1 us-gaap Gain Loss On Sale Of Insurance Block
GainLossOnSaleOfInsuranceBlock
1700000

Files In Submission

Name View Source Status
0001558370-23-007841-index-headers.html Edgar Link pending
0001558370-23-007841-index.html Edgar Link pending
0001558370-23-007841.txt Edgar Link pending
0001558370-23-007841-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kro-20230331.xsd Edgar Link pending
kro-20230331x10q.htm Edgar Link pending
kro-20230331xex31d1.htm Edgar Link pending
kro-20230331xex31d2.htm Edgar Link pending
kro-20230331xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kro-20230331_pre.xml Edgar Link unprocessable
kro-20230331_cal.xml Edgar Link unprocessable
kro-20230331_lab.xml Edgar Link unprocessable
kro-20230331_def.xml Edgar Link unprocessable
kro-20230331x10q_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending